AI Insight
Researchers at Washington University School of Medicine have successfully genetically engineered hookworms to produce and deliver therapeutic drugs inside a living host. The team exploited hookworms' natural ability to survive in the human gut for years by secreting molecules that allow them to coexist with their hosts. This proof-of-concept demonstrates that parasitic worms can be modified to function as drug delivery systems within the body.
Why it matters
This approach could provide a novel method for sustained drug delivery, particularly beneficial for treatments requiring long-term administration. The technology may offer new therapeutic options for chronic diseases, leveraging the parasite's natural survival mechanisms to deliver medications continuously over extended periods.
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable coexistence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for potential human benefit, engineering a hookworm to produce and deliver a drug within a living host.
Source: Genetically modified hookworms produce and deliver therapeutics